Newscast cover image

Can Celeb Support Sign, Seal, Deliver Election Results?

Newscast

00:00

Breakthrough in Alzheimer's Treatment

This chapter discusses the recent approval of Lecanumab, an Alzheimer's drug that has shown the ability to slow disease progression by 25%. It explores the implications for families, the challenges of diagnosis and treatment access, and the ongoing research into future treatments. The conversation also highlights personal stories and the balance between serious health discussions and lighter, more personal anecdotes.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app